Another setback for 5-year old's N$1,3b tender
The High Court has ordered the Central Procurement Board of Namibia (CPBN) not to sign a two-year contract worth N$1,3 billion with Cospharm Investment Pty Ltd for the supply of pharmaceuticals used in cancer treatment and psychotic disorders.